Cytel Executives Invited to Share Clinical Trial Implementation Process Innovations at 65th Deming Conference on Applied Statistics
Nitin Patel and Judith Quinlan to present more efficient approaches and new tools to support the
systematic execution of adaptive clinical trials
Cambridge, MA, USA - July 1, 2009 - Cytel Inc., a leading provider of adaptive clinical trial design services and specialized statistical software, today announced that Cytel Co-Founder and CTO, Nitin Patel and Vice President, Adaptive Clinical Trials Judith Quinlan, have been invited to present at the prestigious 65th Deming Conference on Applied Statistics.
On Wednesday, December 9th from 1:00PM-4:00PM Dr. Patel and Ms. Quinlan will participate as invited speakers in a moderated panel discussing drug supply implementation methodology for adaptive clinical trials. In particular, the panel will emphasize the role of simulations in evaluating design options, and also in helping to quantify the decision making process for selecting the trial plan best able to meet study objectives.
Cytel’s CEO Ranganath Nayak remarked, “The entire Cytel team is honored by Nitin and Judith’s participation in this distinguished forum; the invitation to them makes it clear that Cytel has the capability to go beyond adaptive study design, for which we are well-known, into the implementation of adaptive trials.”
About the Presentation
Session K: Implementation of Adaptive Clinical Trials
December 9th 1:00 PM – 4:00 PM – Atlantic City, NJ
“The audience will see how simulations helped quantify the decision process and importantly, how the impact of drug supply and randomization strategies was integrated into the decision process for the selection of the final design.”
See the Deming Conference website for all topics and participants.
About W. Edwards Deming
W. Edwards Deming is widely considered the father of modern process methodologies for improving productivity through various practices, including the application of statistical methods. His legacy serves as both an inspiration and a practical guide for those in the biopharmaceutical industry devoted to improving clinical development productivity.
About Cytel
Cytel Inc. is a leading provider of clinical trial services and specialized statistical software for the biopharmaceutical, medical device, academic, and government research markets. 47 of the top 50 biopharmaceutical companies rely on Cytel software to design, simulate and analyze adaptive and traditional clinical trials.
Cytel serves trial sponsors with innovative tools, training and consultation to increase the return on investment in clinical development.
For interview requests, or further information contact:
Michael Weitz
Marketing Director
617.661.2011
mike@cytel.com